LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

Intuitive Surgical Inc

Fermé

SecteurSoins de santé

549.2 -2.91

Résumé

Variation du prix de l'action

24h

Actuel

Min

548.95

Max

556.7

Chiffres clés

By Trading Economics

Revenu

45M

709M

Ventes

65M

2.5B

P/E

Moyenne du Secteur

76.318

105.69

BPA

2.4

Marge bénéficiaire

28.31

Employés

15,638

EBITDA

28M

1B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+11.31% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

40B

204B

Ouverture précédente

552.11

Clôture précédente

549.2

Sentiment de l'Actualité

By Acuity

14%

86%

13 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

Intuitive Surgical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

21 oct. 2025, 23:55 UTC

Actions en Tendance

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 oct. 2025, 21:14 UTC

Résultats
Principaux Mouvements du Marché

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 oct. 2025, 20:38 UTC

Résultats

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 juil. 2025, 21:13 UTC

Résultats

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 avr. 2025, 20:55 UTC

Résultats

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

30 oct. 2025, 12:38 UTC

Résultats

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 oct. 2025, 12:01 UTC

Résultats

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 oct. 2025, 15:42 UTC

Résultats

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 oct. 2025, 12:34 UTC

Résultats

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 oct. 2025, 11:49 UTC

Résultats

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 oct. 2025, 20:08 UTC

Résultats

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 oct. 2025, 20:08 UTC

Résultats

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q Net $704.4M >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 juil. 2025, 20:14 UTC

Résultats

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 juil. 2025, 20:13 UTC

Résultats

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 juil. 2025, 20:13 UTC

Résultats

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q Net $658.4M >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 avr. 2025, 20:13 UTC

Résultats

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q Net $698.4M >ISRG

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

Comparaison

Variation de prix

Intuitive Surgical Inc prévision

Objectif de Prix

By TipRanks

11.31% hausse

Prévisions sur 12 Mois

Moyen 611.68 USD  11.31%

Haut 685 USD

Bas 440 USD

Basé sur 20 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

20 ratings

16

Achat

3

Maintien

1

Vente

Score Technique

By Trading Central

514.59 / 539.05Support & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

Weak Bullish Evidence

Long Terme

Strong Bullish Evidence

Sentiment

By Acuity

13 / 374Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat